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Abstract 
The impact of ecstasy/polydrug use on real world memory (i.e., everyday 
memory, cognitive failures and prospective memory) was investigated in a sample of 
42 ecstasy/polydrug users and 31 non-ecstasy users. Laboratory-based prospective 
memory (PM) tasks were administered along with self-report measures of PM to test 
whether any ecstasy/polydrug-related impairment on the different aspects of PM was 
present. Self-report measures of everyday memory and cognitive failures were also 
administered. Ecstasy/polydrug associated deficits were observed on both laboratory 
and self-report measures of PM and everyday memory. The present study extends 
previous research by demonstrating that deficits in PM are real and cannot be simply 
attributed to self misperceptions. The deficits observed reflect some general capacity 
underpinning both time and event-based PM contexts and are not task specific. 
Among this group of ecstasy/polydrug users recreational use of cocaine was also 
prominently associated with PM deficits. Further research might explore the 
differential effects of individual illicit drugs on real-world memory. 
 
 
 
Key Words:  prospective memory, cognitive failures, everyday memory, ecstasy, 
cocaine, cannabis  
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An important topic of investigation that has received increasing attention in 
recent years concerns real world memory processes (i.e., everyday memory, 
prospective memory, and cognitive failures). Examples of everyday memory 
problems and cognitive failures might include for example, forgetting the location of 
familiar objects around the house, forgetting to take essential objects when leaving the 
home or office, failing to recognise acquaintances, or forgetting important events that 
occurred the previous day. Prospective memory (PM) involves remembering to 
execute a particular behaviour at some point in the future, for example, remembering 
to attend a meeting, or meet a friend, or pass on a message. Previous investigations 
from our laboratory in which we evaluated the integrity of real world memory 
processes in ecstasy/polydrug (Montgomery & Fisk, 2007) and cannabis-only users 
(Fisk & Montgomery, 2008) have shown that users of illicit substances exhibit 
deficits in real world memory on a range of measures. Evidence of ecstasy/polydrug 
(Heffernan et al 2001a; 2001b) and cannabis related (McHale & Hunt, 2008) 
impairment has emerged in other studies. Furthermore impairments may be specific to 
particular drugs. For example, Rodgers and co-workers found that cannabis was 
related to short-term and internally cued PM deficits while ecstasy was related to 
deficits in long-term PM (Rodgers et al, 2001; 2003). 
Most of the research into real world memory functioning among users of illicit 
substances has utilised self-report measures (Fisk & Montgomery, 2008; Heffernan et 
al 2001a; 2001b; Montgomery & Fisk, 2007; Rodgers et al 2001; 2003). However, it 
is possible that self perceptions may be distorted. For example, drug users may arrive 
at the laboratory with the expectation that they will under-perform (Bedi & Redman, 
2008; Cole et al, 2006). This may affect their responses on self-report measures 
causing them to imagine or overstate the magnitude of any deficits that might be 
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present. Clearly it would be desirable to confirm the results obtained through self-
report measures utilising laboratory measures of the relevant constructs. To date 
relatively few studies in this area have used laboratory tests of prospective memory. 
Where such tests have been included they have been rather artificial and contrived in 
nature. For example the ‘virtual week’ is a board game completed in the laboratory in 
which the participant is required to complete previously learned tasks at specific 
points as they progress around the board. Deficits were observed on this measure 
among currently abstinent ecstasy users including those who used infrequently 
(Rendell et al 2007). While this test undoubtedly possesses a PM component it has 
been acknowledged that more ecologically valid measures are needed (Will et al 
2009).  In order to address some of these limitations, the present research will include 
laboratory measures of prospective memory which are designed to be more 
naturalistic and where the PM component is less obvious to the participant. 
Cognitive failures and prospective memory are known to utilise prefrontal 
executive processes including the working memory system. Neuroimaging studies 
have revealed the involvement of the frontopolar cortex (Brodmann area 10) and 
neighbouring prefrontal areas during the performance of PM tasks (Okuda et al, 
2007). Other research utilising dual task methodology (Marsh & Hicks, 1998) 
cognitive ageing paradigms (McDaniel et al, 1999) and Parkinson’s related deficits 
(Kliegel et al., 2005) has also linked PM functioning to prefrontal lobe capacity. 
Therefore, if ecstasy or other illicit drugs are associated with real world memory 
deficits among currently abstinent users, then this would provide evidence consistent 
with a disruption of the processes supported by these specific neural locations and in 
particular BA10. 
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Prospective memory tasks may be defined as either event-based or time-based. 
For example, some predefined external event may trigger the retrieval of the intention 
to act, or alternatively the trigger may be the elapse of a given period of time.  Self-
report measures do not adequately capture this distinction and thus while there is 
evidence of self-reported ecstasy/polydrug related deficits in PM it is not clear 
whether users exhibit deficits on one or both types of task. This is an important 
question since there is evidence to suggest that the two classes utilise neural processes 
that are at least in part separable. For example, Burgess et al (2003) and Gilbert et al 
(2005) have shown that event-based tasks utilise the frontopolar cortex, including 
Brodmann area 10 (BA10). More recently PET scanning has revealed that while the 
left superior frontal gyrus was involved in both types of tasks, different areas within 
this structure were found to be activated. Furthermore, in addition to the frontopolar 
cortex, the time-based tasks also activated more diverse regions including anterior 
medial frontal regions, the right superior frontal gyrus and the anterior cingulate 
(Okuda et al, 2007). Thus if ecstasy/polydrug users are differentially affected on time 
and event-based PM tasks then this would provide further information on which 
specific neural locations are susceptible to specific drug-related effects.  
To address these issues laboratory-based and self report measures of PM and 
real world memory were administered. Ecstasy/polydrug related deficits were 
predicted on all measures.  
 
Method 
Participants 
Forty two Ecstasy/polydrug users (Males=14, Females=28) and thirty one non 
users (Males=5, Females=26) took part in this investigation. Participants were 
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recruited via direct approach to university students and the snowball technique i.e. 
mouth to mouth referral (Solowij et al, 1992). All participants were university 
students attending Liverpool John Moores University (LJMU) or the University of 
Central Lancashire (UCLAN).  
 
Materials 
The prior history of illicit drug consumption was assessed using a background 
drug use questionnaire which has been used extensively in previous research from our 
laboratory (e.g., Montgomery et al, 2005a). These data were used to estimate the total 
lifetime use for each drug (e.g. ecstasy, cannabis, amphetamines, cocaine etc). Period 
of abstinence and frequency of use were also assessed. Fluid intelligence was 
measured via Raven’s Progressive Matrices (Raven et al, 1998) and the number of 
years of education, the participant’s age and gender and their current use of cigarettes 
and alcohol were assessed.  
Self-report measures of Real World Memory 
Everyday memory: The Everyday Memory Questionnaire (EMQ, Cornish, 
2000; Sunderland et al. 1983) is a self-report measure of memory lapses in everyday 
activities. The measure consists of 27 statements with responses made on a 9-point 
scale ranging from “not at all in the last 6 months” to “more than once a day”. 
Examples of statements include: “forgetting where you put something”; “finding a 
television story difficult to follow”. A total score is calculated by summing the 
responses to all items.  
Cognitive Failures: The Cognitive Failures Questionnaire (CFQ; Broadbent, 
Cooper, FitzGerald, & Parkes, 1982) is a 25 item measure of everyday attentional 
deficits. Questions include ‘Do you fail to notice signposts on the road?’ and ‘Do you 
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forget what you came to the shops to buy?’ Responses are made on a five-point scale 
with zero corresponding to ‘never’ and four to ‘very often’ yielding a maximum 
possible score of 100. 
Prospective memory Questionnaire (Hannon et al, 1995): The Prospective 
Memory Questionnaire (PMQ) is a self-report measure indicating the likelihood of a 
memory lapse in given time period. The PMQ provides measures of three aspects of 
PM on a scale of 1-9 for each aspect (1 revealing little forgetting, 9 revealing a great 
deal of forgetting). Fourteen questions measure short-term habitual PM, e.g. “I forgot 
to turn my alarm clock off when I got up this morning”. Fourteen items measure long-
term episodic PM, e.g. “I forgot to pass on a message to someone”. Ten questions 
measure internally cued PM, e.g. “I forgot what I wanted to say in the middle of a 
sentence”. In addition, 14 questions make up the “techniques to remember” scale, 
which provides a measure of the number of strategies used to aid remembering. For 
each of the four scales, an average score is calculated by summing the responses and 
dividing by the number of items in that section (14 for ST-habitual, LT episodic and 
strategies and 10 for internally cued). Thus higher scores are indicative of more 
forgetting and many strategies used to aid remembering. 
The Prospective and Retrospective Memory Questionnaire (PRMQ; Crawford 
et al, 2005) provides a measure of memory slips of this kind in everyday life. It 
consists of sixteen items, eight related to prospective memory failures e.g. “Do you 
decide to do something in a few minutes’ time and then forget to do it?” Participants 
were asked to say how often these things happened to them on a 5-point scale: Very 
often, quite often, sometimes, rarely, never, resulting in minimum and maximum 
possible scores of 8 and 40. 
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The reliability and validity of the CFQ, EMQ and PMQ have been 
documented previously (see, for example, Hannon et al, 1995; Royle & Lincoln, 
2008; Wallace, 2004). 
Laboratory measures of Prospective Memory 
Prospective Memory Pattern Recognition Test. This test is based on a 
processing speed task (e.g., see Fisk & Warr, 1996) which was amended so as to 
provide a laboratory-based measure of prospective memory by the addition of a 
parallel prospective memory element. In the pattern comparison speed task, 
participants indicated as quickly as possible whether two patterns appearing on the 
computer screen were the same or different by pressing respectively the "/" key  or the 
"z" key on the keyboard. After each 30 second period the patterns increased in 
complexity and for each level of complexity the computer kept a record of the number 
of correct responses. The prospective memory element of this test required the 
participant to remember to press the ‘F1’ key at the end of each 30 second period 
when the message “please wait a moment” appeared. Participants were told that this 
was in order to save their scores on the task. Failure to press F1 resulted in the score 
for that segment being reported as ‘error’ in the screen display at the end of the task.  
This task was repeated three times. The number of times the participant forgot to 
press F1 for each trial was calculated producing a laboratory event-based prospective 
memory measure. 
Prospective Memory Fatigue Test. At the beginning of the test session, 
participants were told that they should provide an indication of their level of fatigue 
(using the Karolinska Sleepiness Scale: Gillberg, Kecklund, & Akerstedt, 1994) every 
20 minutes throughout the experiment. If the 20 minute period elapsed during the 
completion of a task, participants were asked to complete the fatigue measure 
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immediately after. The percentage of occasions on which the participant remembered 
to complete the Karolinska sleepiness scale was calculated. This was done for the first 
and second half of the test session thereby producing two measures of medium-term 
time-based prospective memory. On each occasion, participants who forgot were 
reminded to fill in the questionnaire. 
Long Term Recall PM. A list of 15 words was presented five times, orally, 
using an audio recording device. At the end of each trial the participant had to write 
down as many words as he/she could recall from the list. No time constrain was 
imposed in this regard. A long-term prospective memory element was added to the 
recall test. Participants had to remember to return an answer sheet to the experimenter 
with the words that they were able to recall after a delay of one, two, and three weeks 
from the time of testing. Three prepaid envelopes were provided for this purpose. 
Participants scored 1 if the envelope was returned and 0 otherwise. This data was 
collected separately for each week but the score was the total number of sheets 
returned (out of a maximum of three). 
These laboratory tasks were based on similar paradigms devised by Mathias 
and Mansfield (2005) and Einstein et al (1995).  
Rivermead Behavioural Memory Test (RBMT-II). A full description of the 
RBMT-II may be found elsewhere (Wilson et al, 1999). In the present study only the 
three subtasks relating to PM were used:  
1) Remembering a hidden belonging. A small object (a pen or pencil in this 
study) was requested from the participant and placed in a specified location. The 
participant was told to remember to retrieve the belonging later doing so when the 
examiner said the words: “We have now finished this test”.  Participants received a 
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score of two if the belonging and location was recalled correctly, one if after a 
prompt, and zero if neither object nor location was remembered.  
2) Remembering an appointment: a timer was set for 20 minutes. The 
participant was told that when the alarm clock rang he/she should ask a pre-arranged 
question (e.g., “What time does this session end”). A profile score of 2 is given if the 
question is recalled correctly, 1 if after prompt or 0 if it is not recalled at all. 
3) Delivering a message. Having first observed the experimenter, the 
participant was required to replicate a short route around the test room depositing a 
message at a specified location on the way. This was done immediately and after a 
delay and a single score was awarded ranging from zero to three depending on the 
number of errors made over the two attempts. 
 
Procedure 
Participants were informed of the general purpose of the experiment and their 
right to withdraw any time. After consent had been obtained the tests were 
administered under laboratory conditions. The drug use questionnaire was 
administered first followed by the Ravens intelligence test, the age/education 
questionnaire, and the prospective memory questionnaires (Crawford et al. 2005 and 
Hannon et al.1995). Next the prospective memory pattern recognition task, the recall 
PM task and the RBMT-II tasks were administered. The fatigue prospective memory 
task was administered throughout the session. Participants were fully debriefed, paid 
20 UK pounds in Tesco store vouchers and given drug education leaflets. The 
University of Central Lancashire’s Ethics Committee approved the study.   
 
Results 
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Demographic and Background Variables 
Inspection of Table 1 reveals that the ecstasy/polydrug users did not differ 
from non-ecstasy users on most of the demographic and background drug use 
variables. Ecstasy/polydrug users consumed significantly more units of alcohol per 
week compared to non-ecstasy users. Although the number of cigarettes consumed 
per day by smokers did not differ significantly between the groups, tobacco use was 
more prevalent among ecstasy/polydrug users with over one half of the group 
currently smoking while less than a third of non-ecstasy users currently smoked 
cigarettes.  
<<Insert Table 1 about here>> 
With regard to illicit drug use, a majority of the ecstasy/polydrug group had in 
the past or were currently consuming cocaine and almost all were cannabis users. 
Around 40% of the group were also amphetamine uses. However, the correlation 
between estimated lifetime use of ecstasy and cannabis, r=.041 (p>.05, n=39), was not 
statistically significant while that between lifetime ecstasy and cocaine use 
approached significance, r=.332 (p=.084, n=28). Estimated lifetime use of cocaine 
and cannabis was also not significantly related r=.172 (p>.05, n=29). Among non 
ecstasy users the use of illicit drugs was largely confined to cannabis, although three 
of the group had also used cocaine. Given the limited use of cocaine and 
amphetamine among non-ecstasy users it was not meaningful to statistically analyse 
group differences in these substances. However, ecstasy/polydrug users had 
significantly greater total lifetime exposure to cannabis compared with non-ecstasy 
users. 
Laboratory Based PM Measures. 
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With regard to the laboratory measures of prospective memory, examination 
of Table 2 reveals that ecstasy/polydrug users were impaired on all but two of the 
measures. With regard to the time-based tasks, remembering to complete the fatigue 
task proved problematic for ecstasy/polydrug users especially during the second half 
of the test session. Overall the completion rate among ecstasy users was only 51% of 
that achieved by nonusers. From a longer-term perspective during the three weeks 
following testing non users posted back 77% more delayed recall response sheets 
compared to users. However, on the time based RMBT-II appointment task, group 
differences were less evident.  
<<Insert Table 2 about here>> 
With regard to the event-based tasks, although ecstasy/polydrug users and 
non-ecstasy users performed similarly on the RMBT-II message task, they performed 
worse on the RMBT-II belonging task. Similarly users were between two and three 
times more likely to forget to press the F1 key during the processing speed task. 
MANOVA with the seven laboratory measures of prospective memory as 
dependent variables and ecstasy/polydrug user group between participants revealed a 
VWDWLVWLFDOO\VLJQLILFDQWHIIHFWRIJURXSȁ ) SSDUWLDOȘ2 = 
.402. As can be seen in Table 2, univariate analyses revealed that all but two of the 
individual measures yielded statistically significant group differences with 
ecstasy/polydrug users consistently performing worse than non-ecstasy users. 
Following the inclusion of covariates relating to lifetime cannabis use (joints) and 
frequency of cannabis use (times per week), the multivariate group effect remained 
statistically significant, ȁ )) = 4.34SSDUWLDOȘ2 = .329. Following 
the inclusion of two further covariates relating to alcohol consumption (units per 
week) and tobacco use (cigarettes per day), again the multivariate group effect was 
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VLJQLILFDQWȁ ) SSDUWLDOȘ2 = .288. Thus the inclusion of 
the four covariates reduced the ecstasy/polydrug user group effect size by 28%. 
However, none of the covariates were statistically significant as predictors of the 
dependent variables, F<1.20, for the multivariate effect, in all cases. Inspection of 
Table 2 reveals that in univariate terms four of the seven dependent variables 
produced statistically significant group differences following inclusion of the 
covariates. Thus with regard to the laboratory measures, ecstasy/polydrug users 
remained impaired relative to non ecstasy users even following the inclusion of the 
covariates. This suggests that the deficits among this group are more likely to be 
attributable to ecstasy.  
Self-Report Real World memory Measures 
Outcomes for the self report measures of real world memory may be found in 
Table 2. With just one exception, it is clear that ecstasy/polydrug users exhibit higher 
scores on all of the measures consistent with a greater incidence of real world memory 
problems. MANOVA with the seven self-report measures of real world memory as 
dependent variables and ecstasy user group between participants revealed a 
VWDWLVWLFDOO\VLJQLILFDQWHIIHFWRIJURXSȁ ) SSDUWLDOȘ2 = 
.244. Inspection of Table 2 reveals that in terms of the univariate analyses, the 
difference between the two groups was statistically significant for four of the seven 
dependent variables. The inclusion of the two measures of cannabis use as covariates 
UHGXFHGWKHPXOWLYDULDWHHIIHFWWRERUGHUOLQHVLJQLILFDQFHȁ )  
S SDUWLDOȘ2 = .214. Furthermore when all four covariates were included (the two 
measures of cannabis use plus the tobacco and alcohol use indicators) the multivariate 
effect was no longer sWDWLVWLFDOO\VLJQLILFDQWȁ 6, F(7,52) = 1.57, p>.05, paUWLDOȘ2 
= .174 and inspection of Table 2 reveals that only one of the univariate analyses 
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continued to yield a statistically significant group difference: the everyday memory 
measure. In multivariate terms, two of the four covariates produced a statistically 
significant effect on the self-UHSRUWUHDOZRUOGPHPRU\PHDVXUHVWRWDOFDQQDELVXVHȁ
 ) SSDUWLDOȘ2  DQGWREDFFRXVHȁ ) 
SSDUWLDOȘ2 = .277. 
Relationship between Period of Abstinence and Memory 
It is possible that some of the drug-related deficits observed in the real world 
memory measures may have been due to short term post intoxication effects. For the 
four main illicit drugs, Table 3 contains the correlations between weeks since last use 
and each of the real world memory measures. Inspection of the Table reveals that for 
the most part the correlations not were statistically significant. With regard to the 
cognitive failures measure, although no ecstasy/polydrug effect was evident in Table 
2, it is clear that performance on the task is correlated with the period of abstinence 
specifically in relation to ecstasy. Those abstaining for longer period self-reported 
fewer cognitive failures. 
<<Insert Table 3 about here>> 
Relationship between Aspects of Drug Use and the Memory Measures 
Table 4 contains the simple Pearson’s correlation coefficients between the 
laboratory and self-report measures of real world memory on the one hand and 
lifetime use and frequency of use of the four main illicit drugs on the other (for non 
users of a particular drug, lifetime and frequency of use have been coded as zero). 
Only those correlations that were statistically significant at p<.05 one tailed are 
displayed. Examination of Table 4 reveals that total lifetime use of both ecstasy and 
cocaine are related to several of the laboratory measures indicating that as the level 
use increases so the real world memory deficits increase in magnitude. With regard to 
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frequency of use, cocaine is significantly correlated with five of the seven laboratory 
measures of real world memory while the frequency of ecstasy use is significantly 
correlated with just three. In all cases increased frequency of use is associated with a 
greater degree of memory impairment. While the defining characteristic of the 
polydrug group is ecstasy use, clearly it appears that cocaine is also implicated in the 
real world memory deficits identified here. 
<<Insert Table 4 about here>> 
With regard to the self-report measures of real world memory, correlations 
with lifetime use are generally larger in absolute magnitude for ecstasy compared to 
cocaine. Similarly, in relation frequency of use, while ecstasy yields significant 
correlations for three of the real world memory measures, only one is statistically 
significant in relation to cocaine use. For all of the statistically significant 
correlations, increased use is associated with higher scores on the self-report measures 
consistent with more real world memory problems. 
While it would have been potentially informative to conduct regression 
analyses with the measures of lifetime use and frequency of use for each drug as 
predictors and the measures of real world memory as dependent variables, this was 
not possible. The sample size was inadequate given the number of predictors and the 
predictors were substantially intercorrelated reflecting the degree of polysubstance 
abuse within the ecstasy/polydrug group. Indeed all but two of the predictors 
possessed tolerances of less than 0.5 rendering testing and interpretation of the 
regression coefficients problematic (Tabachnick & Fidell, 2001).  
However, while the standardised regression coefficients are not especially 
informative in the present context, a comparison of the simple correlation and semi-
partial correlation coefficients does provide an indication of which variables share 
JFisk Page 16 04/12/2013 
statistically significant unique variance with the real world memory measures. Thus, 
where the simple correlations were statistically significant the semi-partial correlation 
between that drug use measure and the real world memory performance was 
computed controlling for the use of the other drugs on the measure in question. Thus 
in relation to the RBMT-II Belonging measure lifetime and frequency of cocaine use 
appear to be important determinants. For the RBMT-II Message measure the 
frequency of cannabis use, and for the long-term recall PM task the frequency of both 
cocaine and cannabis use account for statistically significant unique variance. Of the 
self-report measures lifetime ecstasy use is significantly associated with unique 
variance in the short-term and internally cued Hannon et al (1995) prospective 
memory measures and frequency of ecstasy use with the cognitive failures measure. 
The frequency of cannabis use shares unique variance with the short-term prospective 
memory measure  
Semi-partial correlation is a conservative procedure in which the pooled 
variance between the real world memory measure and two or more of the drug use 
variables is excluded. For a number of the real world memory measures some of the 
simple correlations with drug use were statistically significant while none of the semi-
partial correlations proved to be so. Thus in these cases there is a significant drug-
related effect but it is not possible to identify which drug was likely to be primarily 
responsible. For example, with respect to processing speed task PM errors, total use of 
ecstasy yields a correlation of .284, which implies that the shared variance between 
the two measures was over 8%. However following control for total use of the other 
drugs, the semi-partial correlation was reduced to .177, implying that total ecstasy use 
shared just over 3% of the variance with the processing speed task PM errors measure 
after the overlapping effects of the other drugs were eliminated. The equivalent 
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figures for total use of cocaine were 8% and 2%. Thus in this case, while there is 
evidence of potential cocaine and ecstasy-related effects, similar patterns of use for 
these two drugs in those persons exhibiting different degrees of PM deficits make it 
impossible to identify which drug may be associated with outcomes on this PM 
measure. 
Inter-correlations between the PM and Real World Memory Measures. 
Ignoring for the moment drug-related differences, it would be reasonable to 
expect that the laboratory measures of prospective memory would be correlated with 
each other. However, the correlations would not be expected to be perfect since each 
task would have performance aspects specific to it. Furthermore, the separate tasks 
reflect different aspects of prospective memory functioning such as event-based 
versus time based-tasks and in the latter case PM deficits may be reflected with 
respect to both short term and longer term phenomena. Inspection of Table 5 reveals 
that with the exception of the long term recall task where two of the outcomes only 
approached significance the remaining laboratory tasks did reveal a number of 
statistically significant intercorrelations. Furthermore, for each of the laboratory tasks 
performance was correlated with the scores obtained on one or more of the self report 
measures. Finally, not surprisingly, Table 6 reveals that the outcomes for the self-
report measures were also correlated with each other.  
<<Insert Tables 5 and 6 about here>> 
Discussion 
In multivariate terms ecstasy/polydrug users were found to be impaired on the 
laboratory based PM measures. The group-related effect remained statistically 
significant following controls for lifetime and frequency of cannabis use and current 
use of tobacco and alcohol. In terms of the individual laboratory measures, 
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ecstasy/polydrug users exhibited poorer performance in all cases. These deficits were 
statistically significant on all but two of the measures (the two exceptions were the 
RBMT appointment and message subscales) and remained statistically significant in 
four of the seven measures following controls for cannabis, alcohol and tobacco use. 
In demonstrating that ecstasy/polydrug users were impaired on a variety of PM tasks 
the present study extends previous research in which ecstasy users have been found to 
exhibit impairment on a range of cognitive tasks, for example, selective deficits have 
been observed in aspects of verbal and visuospatial executive functioning, on the 
Tower of Hanoi, and Tower of London tasks, as well as on the Stroop measure (see 
Murphy et al 2009, for a review). Ecstasy users have also exhibited performance 
decrements in aspects of deductive reasoning (Fisk et al 2005). 
Returning to the findings of the present study, with regard to the RBMT-II, 
only the belonging sub-scale yielded statistically significant group differences. To the 
best of our knowledge the present study is the first to demonstrate a deficit on the 
RBMT belonging scale (ecstasy users scored lower on this scale in Zakzanis et al’s 
2003 study, however the difference was not statistically significant). There have been 
few studies investigating ecstasy-related deficits on the RBMT PM measures. 
Zakzanis et al (2003) observed ecstasy-related deficits on the ‘appointment’ and 
‘message’ PM RBMT component measures while neither of these yielded statistically 
significant differences in the present study. It is possible that the deficits observed by 
Zakzanis et al (2003) might have been due to confounding factors. For example, their 
ecstasy users scored significantly lower on the WAIS-III vocabulary sub-test 
compared to the control group. 
The three remaining laboratory based tasks, i.e., the Fatigue PM task 
(remembering to periodically complete the fatigue measure during the test session), 
JFisk Page 19 04/12/2013 
the Processing Speed PM task (remembering to press F1 to store the participant’s 
scores), and the Long-Term Recall PM task (remembering to mail the delayed recall 
test in the successive weeks following the test session) all yielded consistent 
ecstasy/polydrug related deficits which for the most part remained statistically 
significant following the inclusion of the covariates. Furthermore, deficits were 
evident on both time-based (Fatigue PM task) and event based PM tasks (RBMT-II 
Belonging; Processing Speed PM task) which suggests that the ecstasy/polydrug 
deficit reflects some general feature of PM task performance rather than more task-
specific aspects. 
Thus it appears that some aspects of ecstasy use or some other characteristic of 
the ecstasy-using group gives rise to prospective memory deficits independent of any 
effects which might be attributable to cannabis use. This is consistent with the results 
of those studies which have used self-report measures and have found ecstasy-related 
deficits, for example, those from our own laboratory (Montgomery & Fisk, 2007) and 
elsewhere (Heffernan et al 2001a; 2001b; Rodgers et al, 2001; 2003). The present 
results suggest that these deficits are likely to be real rather than imagined and are 
evident in both time- and event-based PM contexts. Ecstasy related deficits were also 
evident on both short-term (fatigue) and long-term (weekly word recall) PM tasks 
although in the latter case the deficit was no longer significant following controls for 
group differences in cannabis use. These results are perhaps somewhat at odds with 
those reported by Rodgers et al, (2001; 2003) who found that, on the basis of self-
reports, ecstasy use was associated with long-term deficits while cannabis use was 
associated with short-term. While the present study is among the first to use a range of 
laboratory based and naturalistic PM measures, previous research using the ‘virtual 
week’ paradigm did reveal ecstasy-related deficits with users performing worse than 
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nonusers on time- and event-based PM components of the task. Furthermore the 
deficits were present in both frequent and infrequent users (Rendell et al, 2007). In a 
subsequent study, methamphetamine users also exhibited deficits on this task (Rendell 
et al, 2009). As noted above the ‘virtual week’ is a board game conducted in the 
laboratory in which the participant is required to complete previously learned tasks at 
specific points as they progress around the board. While this test has its merits, before 
the PM element can be completed it is necessary to learn each of the particular 
responses that is paired with specific locations on the board. Thus the test has a 
substantial associative learning component. Montgomery et al (2005b) have 
demonstrated that ecstasy users are impaired on paired associative learning and so it is 
possible that the deficits evident on the virtual week might be attributable to this 
aspect rather than the PM components. In the present study, the retrospective memory 
element was minimal and little learning was necessary. Thus the PM deficits observed 
here are less likely to be due to associative learning problems. 
While it is noteworthy that the ecstasy/polydrug group differences remained 
statistically significant following the inclusion of the cannabis use measures as 
covariates there are indications that cannabis use may be negatively associated with 
PM. For example the frequency of cannabis use accounted for unique variance in the 
long-term recall PM task with more frequent users returning fewer recall answer 
sheets in the weeks following testing. Furthermore, while there was no 
ecstasy/polydrug related difference on the RBMT message score, the frequency of 
cannabis use again was associated with unique variance on this task with more 
frequent users achieving lower scores. Furthermore the cannabis use measures were 
significantly correlated with a number of the other laboratory PM tasks with greater 
lifetime exposure and increased frequency of use associated with poorer PM 
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performance. However, in these cases the effects were reduced to below statistical 
significance when the shared variance with the other drug use measures was excluded. 
Among ecstasy/polydrug users there was clear evidence that cocaine use was 
associated with adverse outcomes on a number of the laboratory tests of prospective 
memory. As far as the authors are aware the present study is the first to link 
recreational use of cocaine with prospective memory deficits. Either lifetime, or 
frequency of use, or both, were associated with performance on all but one of the 
laboratory measures of prospective memory and one or other of these aspects of use 
were found to share unique variance with three of the PM laboratory measures. As 
noted above PM performance is dependent on pre-frontal executive resources. Of 
particular relevance to the present paper, a number of studies have shown that event 
based PM tasks utilise the frontopolar cortex, i.e., Brodmann area 10 (BA10) (Burgess 
et al, 2003; Gilbert et al, 2005) and the left superior frontal gyrus (Okuda et al, 2007). 
Similarly while time-based PM tasks activated more diverse regions including 
anterior medial frontal regions, the right superior frontal gyrus and the anterior  
cingulate, they also utilised BA10 and the superior frontal gyrus (Okuda et al, 2007). 
Thus the cocaine related deficits observed on both the time and event based laboratory 
PM tasks might be arise from the effects of the drug on the processes supported by 
BA10. 
Neuroimaging studies in normal populations have revealed that the 
dorsolateral prefrontal cortex including BA10 supports a broad range of executive 
functions and in particular those which involve updating the contents of working 
memory (Collette et al 2005). This raises the possibility that cocaine use is associated 
with specific executive function deficits which in turn give rise to PM deficits. Few 
studies of cocaine users have focussed on this particular component executive 
JFisk Page 22 04/12/2013 
process. Deficits among cocaine users have been observed on the paced auditory 
serial addition task (PASAT) (Berry et al 1993; but see also Gonzalez et al, 2004). 
Furthermore, substance dependent polydrug users whose drug of choice was cocaine 
were found to be impaired on a number letter re-sequencing task, and on forward and 
backward digit and spatial span (Verdejo-García & Pérez-García, 2007). These tasks 
all require the contents of working memory to be updated and the results are therefore 
consistent with a cocaine related deficit in the updating component process. 
At the neurotransmitter level dopaminergic activity in the PFC is known to 
underpin executive processes. Equally cocaine is known to influence behaviour 
through its effects on dopamine expression (Heien et al, 2005; Sidiropoulou et al 
2009; Zhang et al, 2005). Unifying these separate aspects, Tomasi et al’s (2007) fMRI 
results demonstrated that compared to controls, cocaine users exhibited 
hypoactivation in the mesencephalon, where dopamine cell bodies are located and 
projections originate, together with a deactivation in dopamine projection regions 
(putamen, anterior cingulate, parahippocampal gyrus, and amygdala). These outcomes 
were associated with a compensatory hyperactivation in cortical regions involved with 
executive functions (prefrontal and parietal cortices). However, during the 
performance of a task loading on working memory resources the activation of these 
prefrontal regions was less than that observed in nonusers. Interestingly, those users 
with urine samples positive for cocaine were significantly less likely to exhibit these 
tendencies relative to abstinent users. Thus Tomasi et al (2007) argue that a prior 
history of cocaine use disrupts the operation of those dopaminergic systems in the 
prefrontal cortex which underpin executive functioning. One manifestation of this 
disruption may be the cocaine-related deficit in PM functioning which could stem 
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from impairment to the updating executive process due the possible susceptibility of 
BA10 to dopamine mediated deficiency. 
A further possibility is that cocaine might give rise to impairment in medial 
temporal and hippocampal processes. Fox et al (2009) observed deficits in various 
aspects of performance on the Rey Auditory Verbal Learning Task (RAVLT) among 
cocaine dependent individuals receiving treatment as inpatients. Deficits in learning 
and recall were related to between group self report stress levels and among cocaine 
users with raised early morning cortisol levels. Fox et al argue that the stress-related 
increase in cortisol levels and associated memory deficits are potentially symptomatic 
of hippocampal damage among cocaine dependent individuals. Such deficits might 
potentially affect the recall component of PM performance and if present among 
recreational cocaine users might therefore provide an explanation for the results 
obtained here. 
While the laboratory PM measures demonstrated clear drug related effects, 
outcomes in relation to the self report measures were less clear cut. Although the 
ecstasy/polydrug group exhibited impairment this was substantially attenuated 
following the inclusion of the other measures as covariates. It may be that although 
ecstasy/polydrug users as a whole are aware of their PM problems they may be 
uncertain as to which illicit drug is responsible for their perceived deficits.  
As with most studies in this area, there are a number of limitations. Due to the 
quasi-experimental design of the study the concurrent use of other illicit drugs may 
have contributed to group differences in PM as the two groups also differed 
significantly on these variables. Also, the purity of MDMA tablets obviously cannot 
be guaranteed (but see Parrott, 2004) and as with previous studies in this area 
(Morgan, 1999; Heffernan et al. 2001a and 2001b) no objective measure of recent 
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drug use such as urinalysis was employed. A further limitation of research of this kind 
is that the apparent ecstasy/polydrug-related deficits may not necessarily be a 
consequence of illicit drug use but perhaps reflect some pre-existing difference 
between users and nonusers which had its origins before the initiation of drug use. 
Consistent with this possibility, in the context of the longer term consequences of 
cannabis use Pope (2002) has emphasised the importance of considering whether or 
not the apparent differences between users and nonusers might reflect pre-morbid 
conditions perhaps in sociodemographic factors, personal dispositions, or underlying 
psychopathology. A further possibility is that the effects observed here may not have 
a direct pharmacological basis but instead be related to lifestyle differences or may be 
due to the effects of drugs on aspects of physiological functioning, for example sleep 
quality (but see Fisk & Montgomery in press; and Montgomery et al, 2007). 
To conclude, the current study intended to determine the impact of 
ecstasy/polydrug use on aspects of real world memory such as everyday memory, 
cognitive failures and prospective memory. Ecstasy/polydrug associated deficits were 
observed on both laboratory and self-report measures of prospective memory. 
Ecstasy/polydrug users were impaired on all PM laboratory measures with the 
exception of one event and one time based PM task from the RBMT-II. 
Ecstasy/polydrug related deficits were also observed in some of the self-report 
measures of PM and in the EMQ while no deficits were observed in the self report 
measures of cognitive failures. We can therefore assume that ecstasy/polydrug users 
possess some self awareness of their memory lapses. An unanticipated finding was 
that the recreational use of cocaine can be associated with prospective memory 
deficits. Further research is needed, to clarify whether the cocaine related deficits are 
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limited to the ecstasy/polydrug population or whether they might be present among 
those persons whose recreational use is largely confined to cocaine. 
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Table 1  Demographical and Background Drug Use Variables for Users and Nonusers  
 
 
 
Ecstasy/Polydrug Users Non Ecstasy Users p 
 Mean S.D. n Mean S.D. n  
        
Age (years) 21.67 3.61 42 21.03 3.25 31 ns 
Ravens Progressive 
Matrices (maximum 60) 
43.32 10.90 42 44.87 7.57 31 ns 
Years of Education 15.05 3.15 42 15.63 1.57 31 ns 
        
Cigarettes per day 9.45 8.60 22 6.33 6.65 9 ns 
Alcohol (Units per 
week) 
14.85 10.11 41 7.17 8.28 30 <.01 
        
Total Use        
   Ecstasy (Tablets) 668.88 1234.67 42 - - - - 
   Amphetamine (grams) 196.00 254.78 13 - - - - 
   Cannabis (joints) 3259.49 4571.12 39 243.00 323.14 10 <.001 
   Cocaine (lines) 1270.71 1762.69 28 255.00 343.65 2 - 
        
Frequency of Use (times 
per week) 
       
   Ecstasy 0.25 0.32 42 - - - - 
   Amphetamine 0.10 0.27 14 - - - - 
   Cannabis 1.02 1.79 39 0.85 1.59 10 ns 
   Cocaine 0.41 0.51 27 0.54 0.65 2 - 
        
Weeks Since Last Use:        
   Ecstasy       4        26 42 - - - - 
   Amphetamine     46   254 16 - - - - 
   Cannabis       2     23 39          18  154 10 ns 
   Cocaine      4   18.5 32           8 5 3 - 
        
Number Ever Used        
   Amphetamine    17    0  
   Cannabis   40   10  
   Cocaine   33   3  
   Ecstasy   42   0  
        
 
 
1. For weeks since last use, median and inter-quartile range are reported. 
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Table 2  Scores on Laboratory and Self-Report Measures of Real World Memory for Users and Nonusers 
 Ecstasy/ 
Polydrug Users 
Non Ecstasy 
Users 
p p  
covariates: 
cannabis use 
p 
Covariates:  cannabis 
smoking, and alcohol 
use 
 Mean S.D. Mean S.D.    
LABORATORY MEASURES        
RBMT-II        
Appointment 1.55 0.77 1.65 0.61 ns ns Ns 
Belonging 1.19 0.77 1.65 0.62 <.01 <.05 <.05 
Message 1.83 0.50 1.87 0.50 ns ns Ns 
        
Fatigue PM Task (% recalled)        
First half of test session  50.44 36.04 72.20 25.57 <.01 <.01 <.05 
Second half of test session 9.48 16.26 44.62 39.52 <.001 <.001 <.001 
        
Processing Speed PM Task Errors 1.64 2.55 0.61 1.23 <.05 <.05 <.05 
        
Long Term Recall PM Task (max 3) 0.95 1.32 1.68 1.30 <.05 ns Ns 
        
SELF-REPORT MEASURES        
Everyday Memory 94.51 36.13 79.42 31.77 <.05 <.05 <.05 
        
Prospective Memory (Hannon et al)        
Short Term 1.53 0.72 1.27 0.38 <.05 <.05 ns 
Long Term 2.81 1.00 2.47 0.88 ns ns Ns 
Internally Cued 2.62 0.96 2.39 0.95 ns ns Ns 
Techniques to Remember 2.74 1.10 3.32 1.58 <.05 ns Ns 
        
Cognitive Failures 43.40 14.20 40.00 12.71 ns ns Ns 
        
Prospective Memory (Crawford et al) 22.63 4.96 20.56 5.52 <.05 <.05 Ns 
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Table 3  Correlations between Real World Memory Measures and Duration of 
Abstinence for the Major Illicit Drugs 
 
 Weeks Since Last Use: 
 
 
 Ecstasy Cannabis Cocaine Amphetamine 
LABORATORY MEASURES     
RBMT-II     
Appointment -.089 .025 .001 -.526* 
Belonging .137 .082 .030 .078 
Message .001 .175 .066 .212 
     
Fatigue PM Task (% recalled)     
First half of test session  .336* .281 .248 .405 
Second half of test session .113 .124 -.128 .192 
     
Processing Speed PM Task Errors -.037 -.182 -.029 -.174 
     
Long Term Recall PM Task (max 3) -.174 .025 .074 -.011 
     
SELF-REPORT MEASURES     
Everyday Memory -.028 -.048 -.126 -.243 
     
Prospective Memory (Hannon et al)     
Short Term -.119 -.043 .165 -.210 
Long Term -.034 -.023 -.033 -.154 
Internally Cued .044 -.155 -.027 -.043 
Techniques to Remember .024 -.110 -.084 .218 
     
Cognitive Failures -.556*** -.147 -.070 -.305 
     
Prospective Memory (Crawford et al) -.151 -.113 -.026 -.119 
 
 
*** p<.001; * p<.05 one-tailed
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Table 4  Correlations between Real World Memory Measures and Lifetime Use and 
Frequency of Use for the Major Illicit Drugs 
 
Real World Memory Measure Drug   Lifetime Use Frequency 
  Simple Semi 
Partial 
Simple Semi 
Partial 
Laboratory Measures      
RBMT-II          
Appointment Cocaine -.258* -.288* -.265* -.210† 
Belonging Ecstasy -.300** -.106     
 Cannabis -.233* -.052     
 Cocaine -.408*** -.238* -.482*** -.440*** 
Message Cannabis   -.264* -.273* 
      
Fatigue PM Task (% recalled)      
First half of test session  Ecstasy   -.238* -.163† 
 Cannabis -.203* -.124 -.247* -.203† 
 Cocaine -.204* -.072 -.244* -.101 
Second half of test session Ecstasy -.231* -.118 -.267* -.167† 
 Cannabis -.254* -.178†   
 Cocaine -.213* -.033   
      
Processing Speed PM Task Errors Ecstasy .284*  .177† .227* .143 
 Cocaine .283* .146 .277* .154 
      
Long Term Recall PM Task (max 3) Cannabis -.276* -.173† -.260* -.207* 
 Cocaine -.254* -.161 -.330** -.271* 
      
Self-Report Measures      
Everyday Memory      
      
Prospective Memory (Hannon et al)      
Short Term Ecstasy .304** .279*   
 Cannabis     .265* .218* 
Long Term      
Internally Cued Ecstasy .377** .361** .271* .181† 
 Amphet-
amine 
    .249* .127 
Techniques to Remember      
      
Cognitive Failures Ecstasy .292*  .212† .350** .251* 
 Cocaine .237*  .027   
 Cannabis .251* -.038   
Prospective Memory (Crawford et al) Ecstasy .330** .188† .253* .100 
 Cocaine .249* .097     
 Amphet-
amine 
.229* .183†   
 
 
*** p<.001; ** p<.01; * p<.05; † p<.10; one-tailed
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Table 5 Inter Correlations between the Laboratory and Self Report Measures of Real World Memory 
 RBMT-II  Fatigue PM Task  Processing Speed PM 
Task 
Long Term Recall 
PM Task 
 Appointment Belonging Message First  
Half 
Second 
Half 
  
LABORATORY MEASURES        
RBMT-II        
Appointment        
Belonging .334**       
Message -.021 .200*      
        
Fatigue PM Task (% recalled)        
First half of test session  .238* .291** .056     
Second half of test session .266* .263* .122 .425***    
        
Processing Speed PM Task Errors -.220* -.270* -.049 -.206* -.185†   
        
Long Term Recall PM Task (max 3) .026 .190† .060 .073 -.028 -.182†  
        
SELF-REPORT MEASURES        
Everyday Memory -.018 -.041 .140 -.063 -.141 -.033 -.094 
        
Prospective Memory (Hannon et al)        
Short Term -.096 -.128 -.003 -.230* -.120 .392*** -.135 
Long Term -.069 -.155 -.139 -.053 -.312** -.006 -.096 
Internally Cued -.021 -.037 -.014 -.077 -.175† -.024 .046 
Techniques to Remember -.041 .072 -.048 .024 -.002 .035 .241* 
        
Cognitive Failures -.174† -.161† .007 -.223* -.323** .108 -.044 
        
Prospective Memory (Crawford et al) -.279** -.190† -.003 -.201* -.281** -.008 -.048 
*** p<.001; ** p<.01; * p<.05; † p<.10; one-tailed 
JFisk Page 37 04/12/2013 
Table 6  Inter Correlations between the Self Report Measures of Real World Memory 
 
 Everyday 
Memory 
Prospective Memory Cognitive Failures 
  Short Term Long 
Term 
Internally 
Cued 
Techniques  
SELF-REPORT MEASURES       
Everyday Memory       
       
Prospective Memory (Hannon et al)       
Short Term .049      
Long Term .442*** .246*     
Internally Cued .455*** .379*** .507***    
Techniques to Remember .254* .211* .366** .577***   
       
Cognitive Failures .477*** .280** .357** .513*** .289**  
       
Prospective Memory (Crawford et al) .615*** .145 .412*** .521*** .328** .707*** 
 
 
*** p<.001; ** p<.01; * p<.05; one-tailed 
 
 
 
 
 
 
 
 
 
